Neurocrine Biosciences, Inc.
NASDAQ: NBIX
$86.55
-$5.04 (-5.5%)
Closing price March 31, 2020
The top analyst upgrades, downgrades and initiations for Friday included Adobe, Biogen, Bristol-Myers, Broadcom, Charles Schwab, Ciena, Etsy, Gilead, Oracle, Sarepta, Snap and Wayfair.
3 months ago
Last Updated: 2 months ago
Credit Suisse and Merrill Lynch made calls in the biotech and pharmaceutical space last week, ahead of coming earnings reports.
5 months ago
Last Updated: 2 months ago
Friday's top analyst upgrades, downgrades and initiations included Agilent Technologies, Alphabet, Altria, Amazon.com, Boeing, Caterpillar, Chipotle Mexican Grill, E*Trade, Gap, Snap and Twitter.
5 months ago
Last Updated: 2 months ago
The top analyst upgrades, downgrades and initiations seen on Wednesday included AIG, Aqua America, CenterPoint Energy, Ferrari, GameStop, Medtronic, Roku, Salesforce.com and Uber Technologies.
9 months ago
Last Updated: 2 months ago
The top analyst upgrades, downgrades and initiations seen on Monday included Amazon.com, Dover, Facebook, Lam Research, Newmont Mining, Occidental Petroleum, Six Flags, Tesla and 3D Systems.
11 months ago
Last Updated: 2 months ago
The top analyst upgrades, downgrades and initiations seen on Thursday included Arena Pharmaceuticals, Autodesk, Coca-Cola, General Electric, Marvell, Monster Beverages, Nabors and Procter &...
1 year ago
Last Updated: 2 months ago
Wells Fargo, Weatherford International, Huntington Bancshares, and Neurocrine Biosciences all posted new 52-week lows Wednesday.
1 year ago
Last Updated: 2 months ago
Neurocrine Bio shares dipped on Wednesday after the company announced that its midstage Tourette syndrome study did not live up to expectations.
1 year ago
Last Updated: 2 months ago
A series of new Stifel research reports focus on three biotech companies that have upcoming clinical data that could prove to be huge.
1 year ago
Last Updated: 2 months ago
With 2018 coming to a close in just a few months, Merrill Lynch is taking a close look at the biotech industry and what key catalysts to expect before 2019.
1 year ago
Last Updated: 2 months ago
The top analyst upgrades, downgrades and initiations seen on Monday include Amazon, Anthem, Constellation Brands, Hecla Mining, Nike, Overstock.com and UnitedHealth.
1 year ago
Last Updated: 2 months ago
Four top growth stocks could be great trades for the balance of 2018 and good to hold into the coming years as they all stand to have continued revenue growth and are solid players in their...
1 year ago
Last Updated: 2 months ago
The top analyst upgrades, downgrades and other research calls from Tuesday include Broadcom, CBS, Etsy, Illumina, PulteGroup, SeaWorld, Wynn Resorts and Zillow.
1 year ago
Last Updated: 2 months ago
While these four stocks are better suited for accounts that have a higher risk tolerance, they all make good sense now and all have outstanding upside potential.
1 year ago
Last Updated: 2 months ago
While there is no guarantee that these four biotech companies are acquired, they are outstanding stocks to own in aggressive growth portfolios on their own.
2 years ago
Last Updated: 2 months ago